Rab14 is overexpressed in ovarian cancers and promotes ovarian cancer proliferation through Wnt pathway
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rab14 is overexpressed in ovarian cancers and promotes ovarian cancer proliferation through Wnt pathway
Authors
Keywords
Rab14, Ovarian cancer, Wnt, Chemoresistance
Journal
TUMOR BIOLOGY
Volume 37, Issue 12, Pages 16005-16013
Publisher
Springer Nature
Online
2016-10-07
DOI
10.1007/s13277-016-5420-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance
- (2015) Anil Belur Nagaraj et al. Oncotarget
- Bioinformatics analysis of Rab GDP dissociation inhibitor beta and its expression in non-small cell lung cancer
- (2014) Zongjuan Ming et al. Diagnostic Pathology
- miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family
- (2014) Feng Ye et al. Journal of Translational Medicine
- Down-regulation of Ras-related Protein Rab 5C-dependent Endocytosis and Glycolysis in Cisplatin-resistant Ovarian Cancer Cell Lines
- (2014) Lixu Jin et al. MOLECULAR & CELLULAR PROTEOMICS
- Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer
- (2014) Lubomir Bodnar et al. Journal of Ovarian Research
- Activation of the PKC Pathway Stimulates Ovarian Cancer Cell Proliferation, Migration, and Expression of MMP7 and MMP101
- (2013) Linah F. Al-Alem et al. BIOLOGY OF REPRODUCTION
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Aberrant Beclin 1 expression is closely linked to carcinogenesis, differentiation, progression, and prognosis of ovarian epithelial carcinoma
- (2013) Yang Zhao et al. TUMOR BIOLOGY
- Overexpression of keratin 17 is associated with poor prognosis in epithelial ovarian cancer
- (2013) Ya-Feng Wang et al. TUMOR BIOLOGY
- WNT7A Regulates Tumor Growth and Progression in Ovarian Cancer through the WNT/ -Catenin Pathway
- (2012) S. Yoshioka et al. MOLECULAR CANCER RESEARCH
- Deregulation of Rab and Rab Effector Genes in Bladder Cancer
- (2012) Joel R. Ho et al. PLoS One
- CIP2A is overexpressed in human ovarian cancer and regulates cell proliferation and apoptosis
- (2012) Yuanyuan Fang et al. TUMOR BIOLOGY
- Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125
- (2011) Michèl Schummer et al. GYNECOLOGIC ONCOLOGY
- MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14)
- (2011) R Wang et al. ONCOGENE
- Rab5a overexpression promoting ovarian cancer cell proliferation may be associated with APPL1-related epidermal growth factor signaling pathway
- (2010) Zhen Zhao et al. CANCER SCIENCE
- Translational research in the Gynecologic Oncology Group: Evaluation of ovarian cancer markers, profiles, and novel therapies
- (2010) Kathleen M. Darcy et al. GYNECOLOGIC ONCOLOGY
- The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment
- (2010) E. Despierre et al. GYNECOLOGIC ONCOLOGY
- Integrin-mediated function of Rab GTPases in cancer progression
- (2010) Dhatchayini Subramani et al. Molecular Cancer
- The chemopreventive retinoid 4HPR impairs prostate cancer cell migration and invasion by interfering with FAK/AKT/GSK3β pathway and β-catenin stability
- (2010) Roberto Benelli et al. Molecular Cancer
- Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy
- (2008) Jia Luo CANCER LETTERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started